Nyxoah SA Current Ratio 2021-2025 | NYXH

Nyxoah SA current ratio from 2021 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Nyxoah SA Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-06-30 $0.06B $0.02B 2.63
2025-03-31 $0.08B $0.02B 3.59
2024-12-31 $0.11B $0.02B 4.56
2024-09-30 $0.09B $0.02B 5.28
2024-06-30 $0.10B $0.02B 5.47
2024-03-31 $0.06B $0.02B 3.94
2023-12-31 $0.07B $0.02B 4.73
2023-09-30 $0.09B $0.02B 5.55
2023-06-30 $0.10B $0.02B 5.99
2023-03-31 $0.11B $0.02B 7.11
2022-12-31 $0.11B $0.02B 6.72
2022-09-30 $0.12B $0.02B 5.97
2022-06-30 $0.14B $0.02B 7.24
2022-03-31 $0.15B $0.01B 10.41
2021-12-31 $0.00B 0.00
2021-06-30 $0.10B $0.02B 6.68
2021-03-31 $0.11B $0.01B 10.36
2020-12-31 $0.11B $0.01B 14.70
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.167B $0.005B
Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $48.330B 58.97
Tempus AI (TEM) United States $12.432B 0.00
Doximity (DOCS) United States $10.168B 42.08
Hims & Hers Health (HIMS) United States $9.340B 75.98
IRhythm Technologies (IRTC) United States $5.625B 0.00
Hinge Health (HNGE) United States $3.490B 0.00
Privia Health (PRVA) United States $2.882B 180.23
Heartflow (HTFL) United States $2.715B 0.00
Inspire Medical Systems (INSP) United States $2.377B 39.32
10x Genomics (TXG) United States $1.898B 0.00
Enovis (ENOV) United States $1.605B 8.43
Omnicell (OMCL) United States $1.601B 32.73
Clover Health Investments (CLOV) United States $1.368B 0.00
Azenta (AZTA) United States $1.346B 58.74
Phreesia (PHR) United States $1.319B 0.00
Schrodinger (SDGR) United States $1.309B 0.00
Claritev (CTEV) United States $1.141B 0.00
Fulgent Genetics (FLGT) United States $0.807B 0.00
Evolent Health (EVH) United States $0.583B 0.00
Talkspace (TALK) United States $0.565B 113.67
Butterfly Network (BFLY) United States $0.563B 0.00
Veradigm (MDRX) United States $0.523B 0.00
Standard BioTools (LAB) United States $0.435B 0.00
Zepp Health (ZEPP) Netherlands $0.396B 0.00
Carlsmed (CARL) United States $0.363B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.295B 0.00
TruBridge (TBRG) United States $0.292B 13.39
CapsoVision (CV) United States $0.221B 0.00
Outset Medical (OM) United States $0.214B 0.00
MDxHealth SA (MDXH) Belgium $0.212B 0.00
Health Catalyst (HCAT) United States $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.180B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.179B 0.00
CareCloud (CCLD) United States $0.147B 8.06
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
Pulmonx (LUNG) United States $0.078B 0.00
NetraMark Holdings (AINMF) Canada $0.075B 0.00
American Well (AMWL) United States $0.068B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
Evaxion - (EVAX) Denmark $0.040B 0.00
111 (YI) China $0.036B 0.00
Precipio (PRPO) United States $0.032B 0.00
Predictive Oncology (POAI) United States $0.026B 0.00
Lunai Bioworks (LNAI) United States $0.022B 0.00
Zhongchao (ZCMD) China $0.018B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Movano (MOVE) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00